HIGHLIGHTS
- who: The Bradycardic Agent Ivabradine et al. from the Purdue University Indianapolis have published the research: The Bradycardic Agent Ivabradine Acts as an Atypical Inhibitor of Voltage-Gated Sodium Channels, in the Journal: (JOURNAL)
- what: Given the diversity of potential future off-label indications for ivabradine, the goal of this study was to investigate the pharmacological action of ivabradine on VGSCs in sufficient detail to gain a better understanding of the pro- and antiarrhythmic effects associated with the administration of this drug. The authors provide additional information regarding the potential molecular basis of the interaction . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.